A detailed history of Umb Bank, N.A. transactions in Xencor Inc stock. As of the latest transaction made, Umb Bank, N.A. holds 137 shares of XNCR stock, worth $2,635. This represents 0.0% of its overall portfolio holdings.

Number of Shares
137
Previous 129 6.2%
Holding current value
$2,635
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

BUY
$19.43 - $26.84 $155 - $214
8 Added 6.2%
137 $3,000
Q3 2024

Oct 08, 2024

BUY
$15.7 - $21.65 $1,020 - $1,407
65 Added 101.56%
129 $2,000
Q2 2024

Jul 29, 2024

BUY
$18.21 - $24.5 $764 - $1,029
42 Added 190.91%
64 $1,000
Q1 2024

Apr 26, 2024

BUY
$18.65 - $26.52 $410 - $583
22 New
22 $0
Q2 2023

Jul 25, 2023

BUY
$24.77 - $29.9 $990 - $1,196
40 New
40 $0

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.15B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Umb Bank, N.A. Portfolio

Follow Umb Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.